Suppr超能文献

脂肪酶的蛋白水解失活可能是胰腺功能不全患者酶替代治疗结果参差不齐的一个原因。

Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.

作者信息

Pap A, Varró V

出版信息

Hepatogastroenterology. 1984 Feb;31(1):47-50.

PMID:6199274
Abstract

Inactivation of lipase in four commercially available pancreatin preparations in buffer solution, in duodenal juice stimulated by secretin-cholecystokinin or by Lundh test-meal, and in duodenal juice supplemented with a meat-meal homogenate, was examined during a four-hour incubation period. In the buffer solution and in the secretin-cholecystokinin-stimulated duodenal juice 64-89% of lipase activity was already lost within two hours. Trypsin activity was in inverse relation to that of lipase and soybean trypsin inhibitor. The Lundh test meal and the meat-meal homogenate significantly diminished inactivation of lipase. Substitution therapy of pancreatic insufficiency with crushed and soybean-trypsin-inhibitor supplemented preparations diminished steatorrhoea more effectively than the simple tablets. The demonstrated proteolytic inactivation of lipase indicates that pancreatic supplements have to be given in crushed or granulated form, well mixed with protein-containing meals, and that a physiological ratio of trypsin-lipase activity ought to be preserved in the preparations.

摘要

在四小时的孵育期内,研究了四种市售胰酶制剂中的脂肪酶在缓冲溶液中、在由促胰液素 - 缩胆囊素刺激的十二指肠液或由伦德试验餐刺激的十二指肠液中,以及在添加了肉粉匀浆的十二指肠液中的失活情况。在缓冲溶液和促胰液素 - 缩胆囊素刺激的十二指肠液中,两小时内64 - 89%的脂肪酶活性已经丧失。胰蛋白酶活性与脂肪酶和大豆胰蛋白酶抑制剂的活性呈负相关。伦德试验餐和肉粉匀浆显著减少了脂肪酶的失活。用粉碎并添加大豆胰蛋白酶抑制剂的制剂替代治疗胰腺功能不全,比单纯片剂更有效地减少了脂肪泻。所证明的脂肪酶的蛋白水解失活表明,胰腺补充剂必须以粉碎或颗粒形式给药,并与含蛋白质的食物充分混合,并且制剂中应保持胰蛋白酶 - 脂肪酶活性的生理比例。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验